Obesity Pharmaco Therapeutics : a Growing Controversy

A growing body of evidence suggest that obesity drugs are showing promise for significant and sustained weight reduction. What are the true benefits, costs, risks and ethical issues surrounding the widespread use of these agents? This talk filmed at the Nutrition LIVE 2024 seminar, describes the current landscape and ongoing issues from the perspective of a clinical endocrinologist.
Neale Cohen
Date:
10 February 2025
Duration:
21:58
Register now to watch this on demand or login if you already have an account.

Associate Professor Neale Cohen is a clinical researcher and Head of the Diabetes Clinical Research Laboratory at the Baker Heart and Diabetes Institute. He is Director of Clinical Services, a Consultant Physician and Head of Pathology at the Baker, as well as holding an Adjunct Clinical Associate Professor position with the School of Public Health and Preventative Medicine, Monash University, and Associate Professor, School of Pharmacy, University of Queensland. His research focus includes technology and management of type 1 diabetes, type 2 diabetes therapeutics, and indigenous diabetes.

This content is available for Healthy Food Guide Pro members only.

Don't worry, registration is free!

Click here to register or login if you already have an account.

More Webinars